a month ago
ARVN
AnalystsJeet MukherjeeJeet Mukherjee's Stock Forecasts
AnalystsJeet Mukherjee
Sectors:
Industries:
Analyst Ranking
Bottom 10%
#4819 out of 5296 analysts
Average Return
-3.06%
Win Rate
41%21 out of 51
Risk vs Reward
Poor
Good
Jeet Mukherjee's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | +92.85% | $45.05 | $86.88 | 2024-12-09 - 2025-12-09 | Strong Buy |
Nurix Therapeutics IncNRIX | +62.98% | $10.40 | $16.95 | 2025-10-22 - 2026-06-12 | Strong Buy |
Kymera Therapeutics IncKYMR | +54.49% | $55.80 | $86.21 | 2025-10-21 - 2026-06-12 | Strong Buy |
Nurix Therapeutics IncNRIX | +38.25% | $12.26 | $16.95 | 2025-11-03 - 2026-06-12 | Strong Buy |
Monopar TherapeuticsMNPR | +33.03% | $44.93 | $59.77 | 2025-09-08 - 2026-06-12 | Strong Buy |
Jeet Mukherjee Analyst Color
Get additional color on Jeet Mukherjee's coverage of popular stocks
4 months ago
PVLA
6 months ago
NRIX
6 months ago
KYMR
Jeet Mukherjee's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Sensei Biotherapeutics IncSNSE | 1 | Strong Buy | $55.00 | +323.08% | Initiates Coverage On | 2 days ago |
Nurix Therapeutics IncNRIX | 7 | Strong Buy | $32.00 | +88.79% | Maintains | 4 days ago |
Immunitybio IncIBRX | 2 | Strong Buy | $12.00 | +69.01% | Reiterates | 23 days ago |
Arvinas IncARVN | 4 | Strong Buy | $18.00 | +137.47% | Maintains | a month ago |
Verastem IncVSTM | 5 | Strong Buy | $18.00 | +339.02% | Maintains | a month ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $125.00 | +334.78% | Reiterates | a month ago |
Ascentage Pharma Group InternationalAAPG | 2 | Strong Buy | $48.00 | +172.73% | Reiterates | 2 months ago |
Aardvark Therapeutics IncAARD | 4 | Strong Buy | $9.00 | +130.77% | Reiterates | 3 months ago |
Perspective Therapeutics IncCATX | 4 | Strong Buy | $14.00 | +374.58% | Reiterates | 3 months ago |
Innate Pharma SaIPHA | 1 | Strong Buy | $8.00 | +354.55% | Assumes | 3 months ago |
Arrivent Biopharma IncAVBP | 1 | Strong Buy | $42.00 | +37.52% | Assumes | 3 months ago |
Kymera Therapeutics IncKYMR | 6 | Strong Buy | $134.00 | +55.44% | Maintains | 4 months ago |
Palvella Therapeutics IncPVLA | 5 | Strong Buy | $215.00 | +97.59% | Maintains | 4 months ago |
Monopar TherapeuticsMNPR | 6 | Strong Buy | $104.00 | +74.00% | Reiterates | 4 months ago |
Bicara Therapeutics IncBCAX | 1 | Strong Buy | $28.00 | +29.09% | Initiates Coverage On | 5 months ago |
Foghorn Therapeutics IncFHTX | 1 | Strong Buy | $11.00 | +163.16% | Initiates Coverage On | 6 months ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.